Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 586-591. doi: 10.3969/j.issn.1671-167X.2015.04.007

• Articles • Previous Articles     Next Articles

A head-to-head comparison of contemporary indolent prostate cancer screen protocols in Chinese

FAN Yu*, LIU Zhuo*, ZHANG Lian, LI De-run, HE Qun, YANG Xin-yu, SHEN Qi, HU Shuai, LIU Li-bo, SHAN Gang-zhi, LI Shu-qing, MENG Yi-sen, WANG Yu, YU Wei, ZHANG Qian, HE Zhi-song, ZHOU Li-qun, JIN Jie△   

  1. (Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: JIN Jie E-mail:jinjie@vip.163.com
  • Supported by:

    Supported by the Beijing Municipal Science and Technology Projects of Beijing Science and Technology Star Project (Z121107002512012), the Beijing Municipal Science and Technology Plan Application Research on the Capital Characteristics (Z131107002213130),the National Natural Science Foundation of China (81370858), and the Central Health Care Research (W2013BJ28)

Abstract:

Objective:To compare the diagnostic accuracy of five internationally used indolent prostate cancer screen protocols in Chinese prostate cancer patients. Methods:Retrospective analysis was made of the consecutive cohort of 314 patients, from Jan. 2006 to Apr. 2014, who had both prostate biopsy and radical prostatectomy in Peking University First Hospital. The Gleason score≤6, pT2, tumor volume≤0.5 mL, margin negative and lymph nodes negative were defined as indolent prostate cancer. The predictive value of five indolent screen criteria including Epstein, Memorial SloanKettering Cancer Center (MSKCC), Prostate Cancer Research International: Active Surveillance (PRIAS), University of California, San Francisco (UCSF), and University of Miami (UM) were evaluated in Chinese prostate cancer patients. Measures of diagnostic accuracy and areas under the receiveroperating curve (AUC) were calculated for each protocol and compared.Results: A total of 16% (49 cases) of the patients met the inclusion criteria of at least one protocol, including 24 cases in Epstein, 33 cases in MSKCC, 28 cases in PRIAS, 34 cases in UCSF, and 22 cases in UM. Three percent were eligible for all the studied criteria. UCSF and MSKCC protocols had the highest sensitivity and specificity than the others. The Epstein and PRIAS protocols demonstrated acceptable positive predictive value, but the specificity and sensitivity were inefficient. The UM protocol was performed unsatisfiedly on sensitivity, positive predictive value and AUC. A strict limited protocol which contained all the five protocols could not improve the predictive accuracy. Conclusion: The UCSF protocol had better diagnostic accuracy than the others, but the results were not satisfied. A further investigation on indolent prostate cancer screening in Chinese patients is needed.

Key words: Prostatic neoplasms, Biopsy, Prostate-specific antigen

CLC Number: 

  • R737.25
[1] ZHOU Guang-ping,ZHOU Qian-yun,ZHU Ji-hong. A case report of TAFRO syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 814-817.
[2] ZHANG Lei,LI Guo-liang,DANG Zong-hui, ,A yong,WU Ling-jie,LIU Li-jun. Analysis of bleeding risk in percutaneous renal biopsy in Tibet [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 298-301.
[3] WANG Ying-chun,HUANG Yong-hui,CHANG Hong,YAO Wei,YAN Xiu-e,LI Ke,ZHANG Yao-peng,ZHENG Wei. Characteristics of benign and malignant lesions of ampullary polyps and the accuracy of forceps biopsy [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 204-209.
[4] Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624.
[5] Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631.
[6] Kui-xia SUN,Cun-ling YAN,Zhi-yan LI,Ping LIU,Wei ZHANG,Qun HE. Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 234-239.
[7] Ye YAN,Hai-zhui XIA,Xu-sheng LI,Wei HE,Xue-hua ZHU,Zhi-ying ZHANG,Chun-lei XIAO,Yu-qing LIU,Hua HUANG,Liang-hua HE,Jian LU. Application of U-shaped convolutional neural network in auto segmentation and reconstruction of 3D prostate model in laparoscopic prostatectomy navigation [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 596-601.
[8] MAO Jia-ming, LIU De-feng,ZHAO Lian-ming,HONG Kai, ZHANG Li, MA Lu-lin, JIANG Hui, QIAO Jie. Effect of testicular puncture biopsy on the success rate of microdissection testicular sperm extraction for idiopathic non-obstructive azoospermia [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 613-616.
[9] ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625.
[10] BI Yong-xiang, XIAO Min-hui, ZHANG Ning-nan, LI Xiao-yun, MAO Xiao-peng, ZHANG Ke, ZHANG Zhuo-rui, ZHAO Liang-yun. Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 590-596.
[11] ZHANG Yu-xiang, MENG Xue-bing, YAO Lin, ZHANG Cui-jian, SONG Gang, CAI Lin, ZHANG Zheng, LI Xue-song, GONG Kan, LI Shu-qing, SHAN Gang-zhi, HE Qun, YANG Xin-yu, HE Zhi-song, ZHOU Li-qun. Percutaneous biopsy of the renal masses under ultrasound: a single-center 14 years experience [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 617-621.
[12] MA Run-zhuo, QIU Min, HE Wei, YANG Bin, XIA Hai-zhui, ZOU Da, LU Min, MA Lu-lin1, LU Jian. Ureteroscope can assist risk stratification in upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 632-637.
[13] LAN Ke, YANG Wen-bo, ZHANG Xiao-wei, BAI Wen-jun, LI Qing, XU Tao. Application of flurbiprofen axetil in pain management associated during transrectal ultrasound-guided prostate biopsy [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 643-647.
[14] JI Guang-jie, HUANG Cong, SONG Gang, LI Xue-song, SONG Yi, ZHOU Li-qun. Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 657-662.
[15] WANG Gong-wei, SHEN Dan-hua, ZHANG Wei-Yu, XU Ke-xin, XU Tao, HU Hao. Trends in Gleason scores of Chinese prostate carcinoma from 1995 to 2014 [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 801-805.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 351 -354 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 369 -373 .